Only two cases (n11 and n14), with a diagnosis of MPN (Myelofibrosis post Essential Thrombocytemia) and AML, had a single mutation in ASXL1, without mutations in the other genes tested. This evidence concerns the gene ASXL1 and myeloproliferative neoplasm.